Manifestaciones gastrointestinales de la enfermedad de Behçet
DOI:
https://doi.org/10.21615/cesmedicina.6771Palabras clave:
enfermedad de Behcet, tracto gastrointestinal, enfermedad intestinal inflamatoriaResumen
La Enfermedad de Behçet (EB), es una entidad poco común, idiopática, de naturaleza crónica y recurrente con afectación multisistémica. Entre ellos, el tracto gastrointestinal ha suscitado especial interés, al asociarse a mayor morbimortalidad y dado sus presentaciones heterogéneas puede simular otras enfermedades gastrointestinales y ser un gran reto diagnóstico para el gastroenterólogo. Por lo tanto, presentamos una revisión narrativa donde se pretenderá describir las manifestaciones gastrointestinales de la EB y sus diagnósticos diferenciales.
Descargas
Referencias bibliográficas
Yazici Y, Hatemi G, Bodaghi B, Cheon J, Suzuki N, Ambrose N, et al. Behçet syndrome. Nature Reviews Disease Primers. 2021;7(1).
Skef W. Gastrointestinal Behçet's disease: A review. World Journal of Gastroenterology. 2015;21(13):3801.
Yazici H, Seyahi E, Hatemi G, Yazici Y. Behçet syndrome: a contemporary view. Nature Reviews Rheumatology. 2018;14(2):107-119.
INTERNATIONALSTUDYGROUPFORBEHC. Criteria for diagnosis of Behcet's disease. The Lancet. 1990;335(8697).
Kim D, Cheon J. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?. Yonsei Medical Journal. 2016;57(1):22.
Hatemi I, Esatoglu S, Hatemi G, Erzin Y, Yazici H, Celik A. Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome. Medicine. 2016;95(16):e3348.
Toro Giraldo A, Pinto Peñaranda L, Velásquez Franco C, Torres Grajales J, Candia Zúñiga D, Márquez Hernández J. Enfermedad de Behcet: experiencia en una cohorte de pacientes colombianos. Revista Colombiana de Reumatología. 2009;16(1):33-45.
MAIN D, CHAMBERLAIN M. CLINICAL DIFFERENTIATION OF ORAL ULCERATION IN BEHÇET'S DISEASE. Rheumatology. 1992;31(11):767-770.
Bayraktar Y, Özaslan E, Van Thiel D. Gastrointestinal Manifestations of Behcet's Disease. Journal of Clinical Gastroenterology. 2000;30(2):144-154.
Jung H, Rhee P, Song I, Choi K, Kim C. Temporal changes in the clinical type or diagnosis of Behcet's colitis in patients with aphthoid or punched-out colonic ulcerations. Journal of Korean Medical Science. 1991;6(4):313.
Ebert E. Gastrointestinal Manifestations of Behçet’s Disease. Digestive Diseases and Sciences. 2008;54(2):201-207.
Mumcu G. Oral health is impaired in Behcet's disease and is associated with disease severity. Rheumatology. 2004;43(8):1028-1033.
Kaklamani V, Tzonou A, Markomichelakis N, Papazoglou S, Kaklamanis P. The Effect of Smoking on the Clinical Features of Adamantiades-Behçet’s Disease. Advances in Experimental Medicine and Biology. :323-327.
Yi S, Cheon J, Kim J, Lee S, Kim T, Lee Y, et al. The Prevalence and Clinical Characteristics of Esophageal Involvement in Patients with Behçet's Disease: A Single Center Experience in Korea. Journal of Korean Medical Science. 2009;24(1):52.
Bottomley W, Dakkak M, Walton S, Bennett J. Esophageal involvement in Behçet's disease. Is endoscopy necessary? Digestive Diseases and Sciences. 1992;37(4):594-597.
ABE T, YACHI A, YABANA T, ISHII Y, TOSAKA M, YOSHIDA Y, et al. Gastric Non-Hodgkin's Lymphoma Associated with Behcet's Disease. Internal Medicine. 1993;32(8):663-667.
Arendt T, Kloehn S, Bastian A, Bewig B, Lins M, Mönig H, et al. A case of Behçet‘s syndrome presenting with Dieulafoy‘s ulcer. Z Gastroenterol. 1997;35(10):935-8.
Ozenç A, Bayraktar Y, Baykal A. Pyloric stenosis with esophageal involvement in Behçet’s syndrome. Am J Gastroenterol 1990; 85: 727-728.
Lankarani KB, Ravanbod MR, Aflaki E, Nazarinia MA, Rajaee A. High prevalence of Helicobacter pylori infection in Behcet's disease. BMC Gastroenterol. 2014;14:58.
Avcı O, Ellidokuz E, Şimşek I, Büyükgebiz B, Güneş A. Helicobacter pylori and Behçet’s Disease. Dermatology. 1999;199(2):140-143.
Çakmak S, Çakmak A, Gül Ü, Sulaimanov M, Bingöl P, Hazinedaroğlu M. Upper gastrointestinal abnormalities andHelicobacter pyloriin Behçet's disease. International Journal of Dermatology. 2009;48(11):1174-1176.
Manna R, Ghirlanda G, Bochicchio G, Papa G, Annese V, Greco A, et al. Chronic active hepatitis and Behçet's syndrome. Clinical Rheumatology. 1985;4(1):93-96.
Maeshima K. Behçet’s disease complicated by multiple aseptic abscesses of the liver and spleen. World Journal of Gastroenterology. 2013;19(20):3165.
Hisaoka M, Haratake J, Nakamura T. Small bile duct abnormalities and chronic intrahepatic cholestasis in Behçet’s syndrome. Hepatogastroenterology. 1994;41:267-270.
Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World Journal of Gastroenterology. 2008;14(18):2858.
Orloff L, Orloff M. Budd-Chiari syndrome caused by Behçet’s disease: treatment by side-to-side portacaval shunt. Journal of the American College of Surgeons. 1999;188(4):396-407.
Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman M. Budd–Chiari syndrome associated with Behçet's disease. Gastroentérologie Clinique et Biologique. 2008;32(3):316-320.
Lakhanpal S, Tani K, Lie J, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: A review of Japanese autopsy registry data. Human Pathology. 1985;16(8):790-795.
Alkim H, Gürkaynak G, Sezgin O, Oğuz D, Saritaş Ü, Şahin B. Chronic Pancreatitis and Aortic Pseudoaneurysm in BehçEt's Disease. American Journal of Gastroenterology. 2001;96(2):591-593.
Lee C, Kim W, Cho Y, Kim M, Kim J, Park I, et al. Colonoscopic Findings in Intestinal Behçet's Disease. Inflammatory Bowel Diseases. 2001;7(3):243-249.
Kim J, Lim S, Choi I, Moon H, Jung H, Song I, et al. Prediction of the Clinical Course of Behçet's Colitis According to Macroscopic Classification by Colonoscopy. Endoscopy. 2000;32(8):635-640.
Moon C, Cheon J, Shin J, Jeon S, Bok H, Lee J, et al. Prediction of Free Bowel Perforation in Patients with Intestinal Behçet’s Disease Using Clinical and Colonoscopic Findings. Digestive Diseases and Sciences. 2010;55(10):2904-2911.
Shen Y, Ma H, Yang Y, Guan J. Ulcerative intestinal tuberculosis case as a complication of treatment by infliximab for intestinal Behçet's disease. Medicine. 2019;98(43):e17652.
Cheon J, Hatemi I, Çelik A. Behçet Syndrome: Gastrointestinal Involvement. Behçet Syndrome. 2019;:117-141.
Valenti S, Gallizzi R, De Vivo D, Romano C. Intestinal Behçet and Crohn’s disease: two sides of the same coin. Pediatric Rheumatology. 2017;15(1).
Harbord M, Annese V, Vavricka S, Allez M, Barreiro-de Acosta M, Boberg K, et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's and Colitis. 2015;10(3):239-254.
Grigg E, Kane S, Katz S. Mimicry and deception in inflammatory bowel disease and intestinal behçet disease. Gastroenterol Hepatol (N Y). 2012;8(2):103-12.
Lee S, Kim B, Kim T, Kim W. Differential diagnosis of intestinal Behçet’s disease and Crohn’s disease by colonoscopic findings. Endoscopy. 2009;41(01):9-16.
Kim D, Cheon J. Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?. Yonsei Medical Journal. 2016;57(1):22.
Shin S, Noh C, Lim S, Lee K, Lee K. Non-steroidal anti-inflammatory drug-induced enteropathy. Intestinal Research. 2017;15(4):446.
Hatemi G, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018 Jun;77(6):808-818).
Yurdakul S, et al. A double-blind trial of colchicine in Behçet’s syndrome. Arthritis Rheum 2001;44:2686–92.
Yazici H, et al. A controlled trial of azathioprine in Behçet’s syndrome. N Engl J Med Overseas Ed 1990;322:281–5.
Hatemi G, et al. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome. N Engl J Med. 2019 Nov 14;381(20):1918-1928).
Sonta T, Araki Y, Koubokawa M, et al. The beneficial effect of mesalazine on esophageal ulcers in intestinal Behcet’s disease. J Clin Gastroenterol 2000;30:195–199.
Hatemi I, et al. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature. Clin Exp Rheumatol. 2015 Nov-Dec;33(6 Suppl 94):S129-37).
Hatemi G, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018 Jun;77(6):808-818.
Santos LB, et al. Infliximab in the treatment of Budd-Chiari syndrome in Behçet's disease. Reumatismo. 2019 Oct 24;71(3):163-165).
Choi IJ, et al. Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum. 2000 May;43(5):692-700.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 CES Medicina
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Derechos de reproducción (copyright)
Cada manuscrito se acompañará de una declaración en la que se especifique que los materiales son inéditos, que no han sido publicados anteriormente en formato impreso o electrónico y que no se presentarán a ningún otro medio antes de conocer la decisión de la revista. En todo caso, cualquier publicación anterior, sea en forma impresa o electrónica, deberá darse a conocer a la redacción por escrito.
Plagios, duplicaciones totales o parciales, traduccones del original a otro idioma son de responsabilidad exclusiva de los autores el envío.
Los autores adjuntarán una declaración firmada indicando que, si el manuscrito se acepta para su publicación, los derechos de reproducción son propiedad exclusiva de la Revista CES Medicina.
Se solicita a los autores que proporcionen la información completa acerca de cualquier beca o subvención recibida de una entidad comercial u otro grupo con intereses privados, u otro organismo, para costear parcial o totalmente el trabajo en que se basa el artículo.
Los autores tienen la responsabilidad de obtener los permisos necesarios para reproducir cualquier material protegido por derechos de reproducción. El manuscrito se acompañará de la carta original que otorgue ese permiso y en ella debe especificarse con exactitud el número del cuadro o figura o el texto exacto que se citará y cómo se usará, así como la referencia bibliográfica completa.
